Concepedia

Dean Tyler

DT

Statistics

Publications

5

Citations

1K

H-Index

5

Active since

2015

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

Peter MacCallum Cancer Centre

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Dean Tyler is an author at Walter and Eliza Hall Institute of Medical Research specializing in molecular oncology, chromatin, and oncology.

Publications per year

2015–2019

5

Publications

5

BET inhibitor resistance emerges from leukaemia stem cells

Chun Yew Fong, Omer Gilan, Enid Y.N. Lam et al. · Nature · 2015 · 548 citations · Full text

, , +14

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

Charles C. Bell, Katie Fennell, Yih-Chih Chan et al. · Nature Communications · 2019 · 180 citations · Full text

, , +17

Click chemistry enables preclinical evaluation of targeted epigenetic therapies

Dean Tyler, Johanna Vappiani, Tatiana Cañeque et al. · Science · 2017 · 143 citations · Full text

, , +17

Functional interdependence of BRD4 and DOT1L in MLL leukemia

Omer Gilan, Enid Y.N. Lam, Isabelle Becher et al. · Nature Structural & Molecular Biology · 2016 · 124 citations · Full text

, , +10

Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors

Phillip P. Sharp, Jean‐Marc Garnier, Tamás Hatfaludi et al. · ACS Medicinal Chemistry Letters · 2017 · 32 citations · Full text

, , +11

1–5 of 5